Patent Assignment
Reel/Frame 058032/0161
Change of Name
Recorded: 2021-11-04
Pages: 42
Assignor
REXAHN PHARMACEUTICALS, INC.
Executed: 2020-11-05
Assignee
OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(21)
Use of Antisense Oligonucleotides to Inhibit the Expression of Human Akt-1
Antisense Oligonucleotides That Inhibit Expression of Hif-1
Quinazoline Derivatives and Therapeutic Use Thereof
Nucleoside Derivatives and Therapeutic Use Thereof
1-[6,7-Substituted Alkoxyquinoxalinyl) Aminocarbonyl]-4-(Hetero) Arylpiperazine Derivatives
5, 6, or 7-Substituted - 3-(Hetero) Arylisoquinolinamine Derivatives and Therapeutic Use Thereof
Quinazoline Derivatives and Therapeutic Use Thereof
Polymeric Systems for the Delivery of Anticancer Drugs
5, 6, or 7-Substituted -3-(Hetero) Arylisoquinolinamine Derivatives and Therapeutic Use Thereof
1-[(6,7-Substituted Alkoxyquinoxalinyl)Aminocarbonyl]-4-(Hetero)Arylpiperazine Derivatives for Treating Tumors
Tetrahydroisoquinolin-2-Yl-(Quinazolin-4-Yl)Methanone Compounds
Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One
Nanoparticulate Compositions and Formulations of Piperazine Compounds
Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One
Tetrahydroisoquinolin-2-Yl-(Quinazolin-4-Yl)Methanone Compounds
Fluorocyclopentenylcytosine Methods of Use
Quinoxalinyl-Piperazinamide Methods of Use
Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One
Nanoparticulate Compositions and Formulations of Piperazine Compounds
Fluorocyclopentenylcytosine Methods of Use
Quinoxalinyl-Piperazinamide Methods of Use
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 1, 2005
From: LEE, SANG K.
To: REXAHN CORPORATION
Reel/Frame 016445/0956 →
Change of Address of Assignee
Aug 18, 2006
From: YOON, HEEJEONG; MAO, LINGJUN; LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN CORPORATION
Reel/Frame 018206/0668 →
Assignment of Assignor's Interest
Aug 18, 2006
From: YOON, HEEJEONG; MAO, LINGJUN; LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN CORPORATION
Reel/Frame 018205/0001 →
Merger and Change of Name
Aug 30, 2007
From: REXAHN CORPORATION
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 019773/0487 →
Assignment of Assignor's Interest
Mar 26, 2008
From: LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN PHARMACETICALS, INC.
Reel/Frame 020705/0717 →
Merger
May 7, 2008
From: REXAHN CORPORATION
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 020940/0901 →
Assignment of Assignor's Interest
May 20, 2008
From: LEE, YOUNG B.; AHN, CHANG H.; CHO, WON-JEA
To: REXAHN, PHARMACEUTICALS, INC.
Reel/Frame 021019/0547 →
Assignment of Assignor's Interest
Jul 17, 2008
From: GONG, YOUNG-DAE; JEON, MOON-KOOK; KIM, DONG-SU; KONG, JAE YANG
To: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; REXAHN PHARMACEUTICALS, INC.
Reel/Frame 021250/0142 →
Assignment of Assignor's Interest
Dec 3, 2010
From: LEE, YOUNG B.; KIM, DEOG J.; AHN, CHANG H.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 025448/0105 →
Assignment of Assignor's Interest
Dec 12, 2012
From: LEE, YOUNG B.; AHN, CHANG H.; CHO, WON-JEA
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 029451/0283 →
Assignment of Assignor's Interest
Feb 26, 2013
From: LEE, YOUNG BOK; AHN, CHANG HO
To: REXAHN PHARMACEUTICALS, INC.,
Reel/Frame 029878/0446 →
Assignment of Assignor's Interest
Oct 11, 2013
From: GONG, YOUNG-DAE; JEON, MOON-KOOK; KIM, DONG-SU; KONG, JAE YANG
To: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; REXAHN PHARMACEUTICALS, INC.
Reel/Frame 031386/0457 →
Assignment of Assignor's Interest
May 29, 2014
From: LEE, YOUNG B.; KIM, JAE M.; KIM, DEOG J.; AHN, CHANG H.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 032990/0986 →
Assignment of Assignor's Interest
Jul 31, 2014
From: FALB, ELIEZER
To: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Reel/Frame 033439/0891 →
Assignment of Assignor's Interest
Jul 31, 2014
From: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 033439/0867 →
Assignment of Assignor's Interest
Jul 31, 2014
From: YIN, HAIFENG; KIM, DEOG JOONG; PEARCEY, LEIGH ANDRE; CUMMINS, JONATHAN
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 033439/0807 →
Assignment of Assignor's Interest
Aug 5, 2014
From: LEE, YOUNG BOK; AHN, CHANG-HO; KIM, DEOG JOONG
To: REXAHN PHARMACEUTICALS, INC.,
Reel/Frame 033462/0286 →
Assignment of Assignor's Interest
Oct 23, 2014
From: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 034022/0201 →
Assignment of Assignor's Interest
Oct 23, 2014
From: WANG, YI; PUROHIT, VIKRAM CHANDRAKANT
To: TEVA PHARMACEUTICAL INDUSTRIES, LTD.; REXAHN PHARMACEUTICALS, INC.
Reel/Frame 034022/0163 →
Assignment of Assignor's Interest
Sep 11, 2015
From: YIN, HAIFENG; KIM, DEOG JOONG; PEARCEY, LEIGH ANDRE; CUMMINS, JONATHAN
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 036588/0756 →
Assignment of Assignor's Interest
Aug 1, 2016
From: LEE, YOUNG BOK; KIM, DEOG JOONG; MAZHARI, REZA; PETERS, GODEFRIDUS J.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 039305/0883 →
Assignment of Assignor's Interest
Sep 29, 2016
From: KIM, DEOG JOONG; LEE, YOUNG BOK; MAZHARI, REZA; EMRICH, DANIEL EDWARD
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 039895/0372 →
Assignment of Assignor's Interest
Jul 2, 2018
From: LEE, YOUNG B.; KIM, JAE M.; KIM, DEOG J.; AHN, CHANG H.
To: REXAHN PHARMACEUTICALS, INC.
Reel/Frame 046253/0779 →